Subscribe

Experts break down regulatory issues in 30 minutes or less.

Explainer Episode 53 – Biologics, Biosimilars, and the Two-fold U.S. Approval Framework’s Possible Impact on Prices

May 16, 2023

Biosimilars, a category of biologic (medicine derived from a living organism), require approval, at least in the U.S. by the…

Listen to this podcast
What Came Next: The FDA's Response

Explainer Episode 52 – What Came Next: FDA’s Response to the Reagan-Udall Foundation’s December Reports on FDA’s Tobacco and Human Foods Program

March 8, 2023

In late February 2023, the FDA released its responses to the December 2022 Regan-Udall Foundation reports on the FDA’s Human Foods and Tobacco programs.

Listen to this podcast

Explainer Episode 51 – Beyond Medicaid? Potential Paths Forward to Better Healthcare

March 7, 2023

In this podcast featuring Tom Miller, he lays out a brief summary of how we got to where we are with regards to Medicaid.

Listen to this podcast

Explainer Episode 50 – FTC on Privacy: The Statutory Authority Behind the Plan

February 17, 2023

Last November, the Federal Trade Commission accepted comments on its proposal to start a rulemaking related to “Commercial Surveillance” – the agency’s newly minted term for any and all business use of data about customers.

Listen to this podcast

Explainer Episode 49 – Utility Rate Modeling

February 8, 2023

Energy consumers continue to see rising rates, but how do regulators decide the rate that consumers pay? In this episode, James Coleman and Mark Ellis explain the relationship between federal and state regulators and utility companies, the financing models behind regulated rates, and the incentives created by these models.

Listen to this podcast

Explainer Episode 48 – The FDA & the Practice of Medicine: Possible Regulation of Off-Label Prescriptions

February 8, 2023

On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 into law. This omnibus law is over 4,100 pages, and, like many omnibus bills, affects a broad range of issues.

Listen to this podcast

Explainer Episode 47 – The Procedure of Title VI & IX Complaints

January 27, 2023

Title VI and IX apply to all colleges and universities that accept federal funds, which, as a condition of accepting those funds, agree they will enforce all Federal Civil Rights laws.

Listen to this podcast

Explainer Episode 46 – The Reagan-Udall Foundation’s December Reports on FDA’s Tobacco and Human Foods Programs: What the Reports Mean and What Comes Next

December 28, 2022

In this podcast, Jeff Stier breaks down some of what the reports say, and what the next steps for both the FDA and Congress may be.

Listen to this podcast

Explainer Episode 45 – Telehealth & COVID-19

December 21, 2022

Health policy experts join us to discuss telehealth regulation – what it is, what happened to it during COVID-19, and what the opportunities and barriers are for future telehealth innovation.

Listen to this podcast

Explainer Episode 44 – The Implications of AI Innovation and Regulation

December 21, 2022

Technology and data privacy experts discuss the evolving landscape of artificial intelligence, machine learning, and what these new technologies mean for existing and future policy and technology innovation.

Listen to this podcast
Skip to content